Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/AK/Anchorage
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Anchorage, AK

Studies commonly pay $75 to $4,500 per completed study

115 clinical trials are currently recruiting participants within 30 miles of Anchorage. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

115studies recruiting
1+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Anchorage right now

Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
Alaska Oncology and Hematology, LLC — Anchorage, Alaska (26.8 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07062965)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Alaska Oncology & Hematology, LLC — Anchorage, Alaska (26.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Metastatic Non-small Cell Lung Cancer With MTAP Deletion Phase 2, Phase 3 Interventional 590 participants sought
Local Institution - 0119 — Anchorage, Alaska (26.8 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07063745)

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

Uncontrolled Gout Phase 3 Interventional 270 participants sought
Orthopedic Physicians Alaska — Anchorage, Alaska (26.8 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07388498)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Alaska Women's Cancer Care — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Phase 3 Interventional 695 participants sought
Alaska Oncology and Hematology — Anchorage, Alaska (26.8 mi) · Sponsor: Gilead Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06801834)

Group Music Therapy for Chronic Pain Management in Active Duty Service Members

Chronic Pain Phase 2 Interventional 130 participants sought
Joint Base Elmendorf-Richardson (JBER) — Anchorage, Alaska (26.8 mi) · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
See eligibility & contact on ClinicalTrials.gov (NCT07755540)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Anchorage, Alaska (26.8 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Phase 2 Interventional 26 participants sought
Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05647265)

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Antineutrophil Cytoplasmic Antibody-associated Vasculitis Phase 4 Interventional 300 participants sought
Orthopedic Physicians Alaska — Anchorage, Alaska (26.8 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT06072482)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Endometrial Cancer Phase 2 Interventional 393 participants sought
Alaska Womens Cancer Care — Anchorage, Alaska (26.8 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT05640999)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Phase 2 Interventional 112 participants sought
Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04511013)

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma Phase 2, Phase 3 Interventional 189 participants sought
Alaska Women's Cancer Care — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05058651)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought
Providence Alaska Medical Center — Anchorage, Alaska (26.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04546399)

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor Phase 2 Interventional 141 participants sought
Anchorage Associates in Radiation Medicine — Anchorage, Alaska (26.8 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05040360)

School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska

Hearing Loss N/A Interventional 8,060 participants sought
Southcentral Foundation — Anchorage, Alaska (26.8 mi) · Sponsor: University of Arkansas
See eligibility & contact on ClinicalTrials.gov (NCT05593484)
Actively enrolling

Studies you may be able to join near Anchorage

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Anchorage

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Aurora Clinical Research

9500 Independence Dr, Anchorage, AK 99507
(907) 759-7559

Clinical trials in Anchorage: what's recruiting

The Anchorage area currently has 115 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Anchorage, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney2 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Anchorage, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Anchorage

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Anchorage participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Anchorage?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Anchorage safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Anchorage?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Anchorage.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Anchorage typically complete one or two studies per year.

Paid clinical trials near Anchorage

Other metros within reach

Bremerton, WA1,482 Olympia, WA228 Marysville, WA204 Seattle, WA1,511 Tacoma, WA1,461 Bellevue, WA1,518 Vancouver, WA1,030 Salem, OR112

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts